204 related articles for article (PubMed ID: 22044775)
61. Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer.
Wanebo HJ; Glicksman AS; Landman C; Slotman G; Doolittle C; Clark J; Koness RJ
Am J Surg; 1995 Nov; 170(5):512-6. PubMed ID: 7485745
[TBL] [Abstract][Full Text] [Related]
62. Anaplastic thyroid carcinoma: dismal outcome despite current treatment approach.
Veness MJ; Porter GS; Morgan GJ
ANZ J Surg; 2004 Jul; 74(7):559-62. PubMed ID: 15230790
[TBL] [Abstract][Full Text] [Related]
63. Long-term results of radiotherapy in anaplastic thyroid cancer.
Dumke AK; Pelz T; Vordermark D
Radiat Oncol; 2014 Mar; 9(1):90. PubMed ID: 24685141
[TBL] [Abstract][Full Text] [Related]
64. [Therapeutic concepts and long-term outcome in thyroid gland carcinoma].
Linder R; Fuhrmann J; Hammerschmidt D
Zentralbl Chir; 1996; 121(6):459-64. PubMed ID: 8767331
[TBL] [Abstract][Full Text] [Related]
65. Anaplastic Thyroid Carcinoma, Version 2.2015.
Haddad RI; Lydiatt WM; Ball DW; Busaidy NL; Byrd D; Callender G; Dickson P; Duh QY; Ehya H; Haymart M; Hoh C; Hunt JP; Iagaru A; Kandeel F; Kopp P; Lamonica DM; McCaffrey JC; Moley JF; Parks L; Raeburn CD; Ridge JA; Ringel MD; Scheri RP; Shah JP; Smallridge RC; Sturgeon C; Wang TN; Wirth LJ; Hoffmann KG; Hughes M
J Natl Compr Canc Netw; 2015 Sep; 13(9):1140-50. PubMed ID: 26358798
[TBL] [Abstract][Full Text] [Related]
66. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.
Choi NC; Herndon JE; Rosenman J; Carey RW; Chung CT; Bernard S; Leone L; Seagren S; Green M
J Clin Oncol; 1998 Nov; 16(11):3528-36. PubMed ID: 9817271
[TBL] [Abstract][Full Text] [Related]
67. Phase I trial of concomitant hyperfractionated radiotherapy with docetaxel and cisplatin for locally advanced head and neck cancer.
Allal AS; Zwahlen D; Becker M; Dulguerov P; Mach N
Cancer J; 2006; 12(1):63-8. PubMed ID: 16613664
[TBL] [Abstract][Full Text] [Related]
68. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10.
Grigsby PW; Lu JD; Mutch DG; Kim RY; Eifel PJ
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):817-22. PubMed ID: 9652843
[TBL] [Abstract][Full Text] [Related]
69. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
70. [Undifferentiated carcinoma of the thyroid gland].
Busnardo B; Girelli ME; Nacamulli D; Pelizzo MR; Daniele O; Rigon A
Chir Ital; 1994; 46(4):37-41. PubMed ID: 7533667
[TBL] [Abstract][Full Text] [Related]
71. Multimodality treatment for anaplastic thyroid carcinoma--treatment outcome in 75 patients.
Swaak-Kragten AT; de Wilt JH; Schmitz PI; Bontenbal M; Levendag PC
Radiother Oncol; 2009 Jul; 92(1):100-4. PubMed ID: 19328572
[TBL] [Abstract][Full Text] [Related]
72. Time trend in tumour size and characteristics of anaplastic thyroid carcinoma.
Han JM; Bae Kim W; Kim TY; Ryu JS; Gong G; Hong SJ; Kim JH; Oh YL; Jang HW; Kim SW; Chung JH; Shong YK
Clin Endocrinol (Oxf); 2012 Sep; 77(3):459-64. PubMed ID: 22458627
[TBL] [Abstract][Full Text] [Related]
73. Surgical options in undifferentiated thyroid carcinoma.
Lang BH; Lo CY
World J Surg; 2007 May; 31(5):969-77. PubMed ID: 17483987
[TBL] [Abstract][Full Text] [Related]
74. Tracheal stenting has minimal impact on survival in anaplastic thyroid carcinoma.
Rajeev P; Ezzat T; Slade M; Sadler GP; Mihai R
World J Surg; 2013 Nov; 37(11):2589-93. PubMed ID: 23912397
[TBL] [Abstract][Full Text] [Related]
75. Dyspnea as a prognostic factor in anaplastic thyroid carcinoma.
Tashima L; Mitzner R; Durvesh S; Goldenberg D
Eur Arch Otorhinolaryngol; 2012 Apr; 269(4):1251-5. PubMed ID: 21932123
[TBL] [Abstract][Full Text] [Related]
76. Alternating radiotherapy and chemotherapy for inoperable Stage III non-small-cell lung cancer: long-term results of two Phase II GOTHA trials. Groupe d'Oncologie Thoracique Alpine.
Mirimanoff RO; Moro D; Bolla M; Michel G; Brambilla C; Mermillod B; Miralbell R; Alberto P
Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):487-94. PubMed ID: 9806505
[TBL] [Abstract][Full Text] [Related]
77. The role of targeted therapy and/or immunotherapy therapy in anaplastic thyroid carcinoma.
Wu G; Song Y; Yang S; Li H; Liu S; Gui L; Ni S
Endocrine; 2024 Jun; 84(3):1013-1020. PubMed ID: 38146047
[TBL] [Abstract][Full Text] [Related]
78. Preoperative chemotherapy and radiation for advanced esophageal carcinoma: comparison between once a day radiation and hyperfractionation, a single-institution experience.
Nguyen NP; Leonardo JM; Karlsson U; Salehpour M; Vos P; Robiou C; Moran JF; Thomas P; Bullock L; Ludin A; Jendrasiak G; Sallah S
Am J Clin Oncol; 2002 Aug; 25(4):358-64. PubMed ID: 12151965
[TBL] [Abstract][Full Text] [Related]
79. Role of surgery in the management of anaplastic thyroid carcinoma: Korean nationwide multicenter study of 329 patients with anaplastic thyroid carcinoma, 2000 to 2012.
Baek SK; Lee MC; Hah JH; Ahn SH; Son YI; Rho YS; Chung PS; Lee YS; Koo BS; Jung KY; Lee BJ
Head Neck; 2017 Jan; 39(1):133-139. PubMed ID: 27534388
[TBL] [Abstract][Full Text] [Related]
80. Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center.
Athanasiadis I; Taylor S; Vokes EE; Pelzer HJ; Rademaker A; Mittal BB; Ganzenko N; Blough R; Lester EP; Kies MS
Cancer; 1997 Feb; 79(3):588-94. PubMed ID: 9028372
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]